What You Should Know:
- Eli Lilly is awarded Emergency Use Authorization (EUA) by the FDA for its monoclonal antibody for the treatment of recently diagnosed, mild to moderate COVID-19 in high-risk patients.
- U.S. government
will allocate 300,000 doses of bamlanivimab to high-risk patients, with no
out-of-pocket costs for the medication.
The U.S. Food and Drug Administration (FDA) today granted
Emergency Use Authorization (EUA) for Eli
Lilly and Company's (NYSE: LLY)
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Cytek Biosciences Raises $120M To Expand Spectral Cell Analysis Systems
What You Should Know:
- Cytek Biosciences raises 120M in Series D funding –
underscoring the company’s growing momentum and significant contributions to
the field of cell analysis.
- Cytek, whose innovative flow cytometers represent the
first big technological leap in flow cytometry in decades, is currently
transitioning into a complete solution provider for the cell analysis market.
- This most recent funding round accelerates this transition and helps the company expand support for
Read More
Mammoth Lands 2 Major Partnerships to Use CRISPR to Solve COVID19 Testing Shortage, At Scale
What You Should Know:
- Mammoth Biosciences signs agreements
with MilliporeSigma and Hamilton company targeting commercialization of high-throughput
CRISPR-based SARS CoV-2 Test.
- These partnerships will help Mammoth bring a turnkey CRISPR-based sample-to-answer solution for commercial laboratories to enable a multi-fold increase in a testing capacity.
Mammoth
Biosciences, Inc., announced that it has signed agreements with
MilliporeSigma and Hamilton Company targeting
Read More
Mission Bio Launches Single-Cell Multi-Omics System for Precision Cancer Therapies
What You Should Know:
- Mission Bio launches industry’s first and only
single-cell multi-omics platform, is announcing the launch of its most
comprehensive instrument to-date, to save the industry billions of dollars in
drug development costs and bring life-saving treatments to market at least six months
faster.
- Mission Bio’s Tapestri Platform, the first single-cell platform capable of detecting DNA and protein changes simultaneously, gives a profound insight into the mutations that
Read More
Medidata, TriNetX, Datavant Partner to Accelerate Use of RWD
What You Should Know:
- Today, Medidata, TriNetX, and Datavant announced a
partnership to accelerate the use of real-world data (RWD) to power clinical
research.
- Linking RWD, which is data not collected during the specific context of a clinical trial, can help improve understanding of the long-term safety and efficacy of new therapies.
Medidata, a Dassault Systèmes company, TriNetX, and Datavant announced a partnership that will accelerate the use of real-world data (RWD) to
Read More
CVS Health Adds 1,000 COVID-19 Rapid-Result Testing at Retail Pharmacy Locations
What You Should Know:
- CVS Health announced plans to expand COVID-19 testing
services by offering rapid-result testing at select CVS Pharmacy locations and
through the company’s return to work COVID-19 testing solution, Return Ready.
- Rapid-result tests can help to slow the spread of the virus, especially when combined with other preventive measures including social distancing and “mask-wearing” because it provides patients with the opportunity for a quick diagnosis, appropriate
Read More
LabCorp Launches Fully Integrated Clinical Trial Platform to Streamline Drug Development Process
What You Should Know:
- LabCorp launches fully integrated clinical trial platform to streamline the drug development process featuring
- The new clinical trial platform will deliver dramatic reductions in patient and study site administrative tasks, improve trial resiliency, and maintain study continuity through the use of the company’s data, technology, and direct-to-patient outreach capabilities.
Global life sciences company LabCorp today announced new capabilities that
Read More
Ori Biotech Lands $30M for Cell and Gene Therapy Manufacturing Platform
What You Should Know:
- Biotech startup Ori Biotech raises $30M in Series A
funding to scale its cell and gene therapy (CGT) manufacturing platform.
- Ori Biotech helps pharmaceutical and biotech companies
develop and manufacture cell and gene therapies. Its patented technology aims
to reduce the manufacturing cost of these life-saving treatments by up to 80%,
allowing them to be more widely accessible for patients.
Ori Biotech Ltd (Ori),
a leading innovator in cell and gene therapy
Read More
Is Glucometrics The Missing Data in the Fight Against COVID-19?
Glucometrics – the system-wide analysis of inpatient glucose data – should be of fundamental interest for hospital administrators striving to improve the outcomes of their patients.
Why is this data so important? Proper glycemic control has been linked to improved outcomes and decreased length of stay time and time again across a myriad of conditions – whether it’s someone recuperating from a heart attack, battling pneumonia, or recovering from surgery.
The U.S. health system lacks
Read More
Growth in the Adoption of 3D Printing Technology After COVID-19 Isn’t A Coincidence
The concerning additive manufacturing media keeps on getting notifications about how the 3D printing technology keeps on growing. Both, through news stories, as well as through blogs from the 3D printing community. However, only after the coronavirus pandemic spread enough, people realized how other manufacturing options are not as effective as 3D printing is. More and more news stories about how 3D printers can work as a solution to supply chain challenges came to the notice of people. And, all
Read More
